Patrick L McGeer

Aurin biotech is a private corporation established to develop clinical applications of agents that can block self attack by aberrant complement activation. Such attack has been reported to occur in many human diseases. Aurin Biotech is a pre-clinical stage company dedicated to the development of novel agents with the potential for breakthroughclinical applications. Our mission is to help to fill the enormous need for safe, effective, and orally available therapeutics capable of controlling abnormal activation of the body’s complement system.